Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Immunovant Inc (NQ: IMVT ) 26.89 +0.69 (+2.61%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 603,169 Open 26.04 Bid (Size) 25.77 (3) Ask (Size) 27.08 (5) Prev. Close 26.20 Today's Range 25.96 - 27.00 52wk Range 18.16 - 45.58 Shares Outstanding 114,998,871 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News After Biohaven Kerfuffle, Immunovant Dives On A Surprise Delay May 30, 2024 Immunovant, which jumped Wednesday on news from rival Biohaven, reversed course Thursday. Via Investor's Business Daily IMVT Stock Earnings: Immunovant Misses EPS for Q4 2024 May 29, 2024 IMVT stock results show that Immunovant missed analyst estimates for earnings per share the fourth quarter of 2024. Via InvestorPlace Performance YTD -35.04% -35.04% 1 Month +5.02% +5.02% 3 Month -14.60% -14.60% 6 Month -37.16% -37.16% 1 Year +40.83% +40.83% More News Read More 12 Health Care Stocks Moving In Wednesday's After-Market Session May 29, 2024 Via Benzinga Biohaven Stock Stumbles As Protein-Degrading Drug Falls Short Of Expectations In Early-Stage Study May 29, 2024 Via Benzinga Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session May 29, 2024 Via Benzinga Recap: Immunovant Q3 Earnings February 12, 2024 Via Benzinga Heico Posts Upbeat Earnings, Joins Surmodics, Abercrombie & Fitch And Other Big Stocks Moving Higher On Wednesday May 29, 2024 Via Benzinga Biohaven Crashes After Protein-Degrading Drug Misses Expectations; Immunovant, Argenx Jump May 29, 2024 Via Investor's Business Daily Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich March 25, 2024 Via InvestorPlace Argenx, Immunovant Soar — As Tourmaline Plummets — On A Rival's Lackluster Test Results March 21, 2024 Via Investor's Business Daily Argenx Dives On Autoimmune Therapy Failure December 20, 2023 Via Investor's Business Daily 12 Health Care Stocks Moving In Thursday's Pre-Market Session March 21, 2024 Via Benzinga 3 Under-the-Radar Biotech Stocks With Upcoming Catalysts in 2024 February 26, 2024 Via InvestorPlace 7 Russell 2000 Stocks to Buy for the Next Bull Run: February 2024 February 06, 2024 Via InvestorPlace 3 Top-Rated Russell 2000 Stocks Wall Street Analysts Are Loving Now: January 2024 January 19, 2024 Via InvestorPlace 5 Biotech Stocks That Could Be Big Winners in 2024 and Beyond January 15, 2024 Via The Motley Fool Stock Market Rally Is In Merry Mood Heading Into Christmas Weekend: Weekly Review December 22, 2023 Via Investor's Business Daily Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session December 21, 2023 Via Benzinga Immunovant Scores Much-Needed Win Following Argenx-Led Sell-off December 21, 2023 Via Investor's Business Daily Autoimmune Disease Player Immunovant's Investigational Drug For Immune System Disorder Shows Response Rates Of Over 50% December 21, 2023 Via Benzinga Amazon.com To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Thursday December 21, 2023 Via Benzinga Micron Posts Upbeat Sales, Joins Calliditas Therapeutics And Other Big Stocks Moving Higher In Thursday's Pre-Market Session December 21, 2023 Via Benzinga Topics Stocks Exposures US Equities Roivant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease December 20, 2023 From Roivant Sciences Via GlobeNewswire Why Steelcase Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session December 20, 2023 Via Benzinga FedEx Posts Downbeat Earnings, Joins Steelcase, argenx And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session December 20, 2023 Via Benzinga Topics Stocks Exposures US Equities Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
